Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Tolerability
100%
Intralesional Bleomycin
100%
Clinical Practice
40%
Methodologic Quality
40%
Adverse Events
20%
Embase
20%
Randomized Clinical Trial
20%
PubMed
20%
Inclusion Criteria
20%
MEDLINE
20%
Web of Science
20%
Cure Rate
20%
Clinical Evidence
20%
Erythema
20%
Evidence-based Recommendations
20%
Off-label Use
20%
Cochrane
20%
Warts
20%
Cochrane Collaboration
20%
Cutaneous Metastasis
20%
Bleomycin
20%
Multicenter Randomized Controlled Trial
20%
Treatment Indication
20%
Non-melanoma Skin Cancer
20%
Risk of Bias Assessment
20%
Exclusion Criteria
20%
Systemic Side Effects
20%
Google Scholar
20%
Hemangioma
20%
Recalcitrant Warts
20%
Ovid
20%
Hypertrophic Scar
20%
Keloid Scar
20%
Collaboration Risk
20%
Common Warts
20%
Eschar
20%
Medicine and Dentistry
Systematic Review
100%
Dermatology
100%
Bleomycin
100%
Verruca Vulgaris
50%
Adverse Event
33%
Dermatological Agent
33%
Randomized Clinical Trial
16%
Controlled Clinical Trial
16%
Critical Appraisal
16%
Erythema
16%
Venous Ulcer
16%
Skin Metastasis
16%
Non Melanoma Skin Cancer
16%
Hemangioma
16%
Treatment Indication
16%
Keloid
16%
Hypertrophic Scar
16%
Eschar
16%